series-b
Stage
1
Investors
About
ProMIS Neurosciences is a clinical-stage biotechnology company developing selective antibody therapies targeting toxic misfolded proteins implicated in neurodegenerative diseases such as Alzheimer's, ALS, Parkinson's, and others.
Explore ProMIS Neurosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.